Q1
LONG ANSWER
10M
★ High-yield
Define autacoids. Describe histamine, its receptors and actions, and classify the antihistamines with their uses.
Definition and Synthesis
Autacoids ("self-remedies") are locally acting substances produced by the body that act near their site of release and are rapidly destroyed — histamine, serotonin, prostaglandins, leukotrienes, kinins, nitric oxide and cytokines.
- Histamine is formed from histidine by histidine decarboxylase, and destroyed by histaminase (diamine oxidase) and by methylation
- Stored in — mast cell and basophil granules (bound to heparin), enterochromaffin-like (ECL) cells of the gastric mucosa, and histaminergic neurons of the posterior hypothalamus
Histamine Receptors
| Receptor | G protein | Location | Effects |
|---|---|---|---|
| H1 | Gq | Smooth muscle, endothelium, sensory nerves, CNS | Bronchoconstriction; vasodilatation and increased capillary permeability (oedema); itch and pain; wakefulness |
| H2 | Gs | Gastric parietal cells, heart, uterus | Gastric acid secretion; tachycardia and increased contractility; vasodilatation |
| H3 | Gi | Presynaptic, in the CNS | Autoreceptor — inhibits further histamine release |
| H4 | Gi | Eosinophils, mast cells, bone marrow | Chemotaxis; a target in allergic and inflammatory disease |
Actions of Histamine
- Cardiovascular — arteriolar vasodilatation (H1 and H2) with a fall in blood pressure; increased capillary permeability causing oedema; direct cardiac stimulation (H2)
- The triple response OF LEWIS after intradermal injection — (1) a red spot from local capillary dilatation; (2) a bright red flare spreading outward, from arteriolar dilatation mediated by an axon reflex; (3) a wheal from increased permeability and oedema
- Respiratory — bronchoconstriction, marked in asthmatics; increased bronchial secretion
- Gastric — powerful stimulation of acid secretion through H2 receptors; histamine is the final common mediator of acid secretion, which is why H2 blockers work whatever the stimulus
- Nerve endings — itching and pain
- Histamine releasers — morphine, tubocurarine, vancomycin (causing "red man" syndrome if infused rapidly), radiocontrast media, polymyxin B, and the anaphylatoxins C3a and C5a
CLINICAL PEARL
The flare of the triple response is not a local effect at all. It spreads well beyond the injection site because impulses travel antidromically along sensory nerve branches — the axon reflex — releasing vasodilator peptides some distance away. That is why the flare is abolished by nerve section and degeneration, while the spot and wheal persist.
Antihistamines — Classification
| Generation | Drugs | Features |
|---|---|---|
| First generation (sedating) | Chlorpheniramine, promethazine, diphenhydramine, hydroxyzine, cyclizine, cinnarizine, dimenhydrinate | Lipid-soluble, cross the blood–brain barrier — sedation; also antimuscarinic (dry mouth, blurred vision, retention), antiemetic and anti-motion-sickness; short-acting |
| Second generation (non-sedating) | Cetirizine, loratadine, fexofenadine, desloratadine, bilastine | Poorly lipid-soluble and substrates of P-glycoprotein, so they do not enter the CNS; no antimuscarinic effect; longer acting, once daily |
| Withdrawn | Terfenadine, astemizole | Caused QT prolongation and torsades DE pointes when metabolism was inhibited by erythromycin or ketoconazole — the classic example of a metabolic interaction causing a fatal arrhythmia |
Uses of H1 Antihistamines
- Allergic disorders — allergic rhinitis, urticaria, angio-oedema, atopic dermatitis, drug and insect-bite reactions, conjunctivitis
- They relieve itch, sneezing and rhinorrhoea well, but nasal blockage poorly, since congestion is largely mediated by leukotrienes
- Motion sickness and vertigo — promethazine, cinnarizine, dimenhydrinate; effective through their antimuscarinic and central actions, so only first-generation drugs work
- Nausea and vomiting, including of pregnancy (doxylamine with pyridoxine) and of vestibular origin
- Sedation and insomnia — promethazine, diphenhydramine; a short-term measure only
- Common cold — symptomatic relief comes from the antimuscarinic drying effect, not from any antihistamine action
- As an adjunct in anaphylaxis — but never as the primary treatment, which is adrenaline
Anaphylaxis — the Clinical Consequence of Mass Histamine Release
| Feature | Mediator and mechanism | Treatment |
|---|---|---|
| Hypotension and shock | Histamine and other mediators cause vasodilatation and massive capillary leak; up to a third of plasma volume can shift in minutes | Adrenaline intramuscularly; large-volume intravenous fluids |
| Bronchospasm | H1-mediated, with leukotrienes | Adrenaline; nebulised salbutamol |
| Angio-oedema and laryngeal obstruction | Increased vascular permeability | Adrenaline; early airway assessment and intubation if threatened |
| Urticaria and itch | H1 on sensory nerves | Antihistamine — symptomatic only |
| Biphasic recurrence | Late-phase mediator release, hours after apparent recovery | Observation for 6–12 hours; corticosteroid is given for this, not for the acute event |
- Adrenaline is the only drug that reverses every feature, and it must be given intramuscularly into the anterolateral thigh without waiting for intravenous access — 0.5 mg of 1:1000 in an adult, repeated after 5 minutes if needed
- Antihistamines and steroids are adjuncts, never the primary treatment; deaths continue to occur because an antihistamine was given while adrenaline was delayed
- Anaphylactoid reactions — clinically identical but caused by direct mast cell degranulation without IgE, so they can occur on first exposure; caused by radiocontrast, vancomycin, opioids and NSAIDs
- Patients on beta-blockers may respond poorly to adrenaline; glucagon is used, as it raises cardiac cAMP by a route that bypasses the blocked receptor
Adverse Effects and Applied Aspects
- First generation — sedation and impaired psychomotor performance (dangerous when driving or operating machinery, and additive with alcohol), dry mouth, blurred vision, urinary retention, constipation, and confusion in the elderly
- Contraindicated or used with care in glaucoma and prostatic enlargement, because of the antimuscarinic action
- Avoid first-generation drugs in the elderly, in whom they contribute substantially to anticholinergic burden, falls and delirium
- Antihistamines do not prevent anaphylaxis and must never delay adrenaline — a recurring and lethal error
- H2 blockers — ranitidine, famotidine, cimetidine; used for peptic ulcer and reflux. Cimetidine is a potent enzyme inhibitor and has antiandrogen effects (gynaecomastia, impotence); famotidine and ranitidine do not
- Widely sold over the counter in India in cold and cough preparations, often combined irrationally; sedation in a driver or a student is a real and unrecognised harm
- Antihistamines do not work well for nasal blockage, which is leukotriene-mediated; an intranasal corticosteroid is the more effective treatment for allergic rhinitis
- Cetirizine causes more sedation than loratadine or fexofenadine in a minority of patients, so "non-sedating" should not be taken as absolute
- Every patient who has had anaphylaxis needs an adrenaline auto-injector, training in its use, a written plan, and referral for allergy assessment to identify the trigger
- Chlorpheniramine remains widely used and useful in India because it is cheap and available parenterally, but its sedative and antimuscarinic effects must be weighed, particularly in the elderly
- H2 blockers have largely been displaced by proton pump inhibitors for acid suppression, though famotidine retains a place where a proton pump inhibitor is unsuitable
- Ranitidine was withdrawn worldwide after nitrosamine contamination was found, and famotidine is now the usual alternative
- Warn patients about driving and machinery when prescribing any first-generation antihistamine, and about the additive effect of alcohol
All questions in Autacoids, Nsaids & Antigout
- Q1Define autacoids. Describe histamine, its receptors and actions, and classify the antihistamines with their uses. ★
- Q2Describe the synthesis of eicosanoids. Compare COX-1 and COX-2 and classify the NSAIDs with their actions and adverse effects. ★
- Q3Describe the pharmacology of aspirin including its dose-dependent actions, uses, adverse effects and poisoning. ★
- Q4Describe the drugs used in rheumatoid arthritis including NSAIDs, DMARDs and biological agents. ★
- Q5Describe the drugs used in acute and chronic gout with their mechanisms and adverse effects. ★
- SN1Describe the selective COX-2 inhibitors with their advantages and the reason for the withdrawal of rofecoxib. ★
- SN2Describe the pharmacology of paracetamol and the management of paracetamol poisoning. ★
- SN3Describe the drugs used in the treatment and prophylaxis of migraine. ★
- SN4Describe 5-hydroxytryptamine, its receptors and the drugs acting on them. Add a note on serotonin syndrome. ★
- SN5Describe the therapeutic uses of prostaglandins and their analogues. ★
- SN6Describe NSAID-induced peptic ulceration and its prevention. ★
- SN7Describe nitric oxide with its synthesis, actions and therapeutic exploitation.